Literature DB >> 8986741

Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease.

D R Archer1, P A Cuddon, D Lipsitz, I D Duncan.   

Abstract

There is a lack of effective means of promoting remyelination of the central nervous system (CNS) in humans with chronic demyelinating disease. We have investigated the ability of transplanted glia to myelinate areas of the CNS equivalent to focal demyelinated lesions in multiple sclerosis (MS). In these studies we show that transplantation of oligodendrocytes or their progenitors into the CNS of a neonatal or adult canine myelin mutant results in repair of large areas similar in size to many MS plaques. Progenitor or pre-progenitor cells of the oligodendrocyte lineage have the greatest capacity for myelination following grafting, although cells of neonatal origin may also be used. Such an approach may therefore have therapeutic value in the repair of focal lesions in human myelin disease.

Entities:  

Mesh:

Year:  1997        PMID: 8986741     DOI: 10.1038/nm0197-54

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  26 in total

1.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination.

Authors:  J W Bulte; S Zhang; P van Gelderen; V Herynek; E K Jordan; I D Duncan; J A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity.

Authors:  S C Zhang; B Ge; I D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Stem cell transplantation in multiple sclerosis: current status and future prospects.

Authors:  Gianvito Martino; Robin J M Franklin; Anne Baron Van Evercooren; Douglas A Kerr
Journal:  Nat Rev Neurol       Date:  2010-04-20       Impact factor: 42.937

Review 4.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 5.  Prospects for neural stem cell-based therapies for neurological diseases.

Authors:  Jaime Imitola
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 6.  Genetic aspects of Charcot-Marie-Tooth disease.

Authors:  C Bell; N Haites
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

7.  Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve.

Authors:  J Shi; A Marinovich; B A Barres
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

8.  High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility.

Authors:  Chunlei Liu; Wei Li; G Allan Johnson; Bing Wu
Journal:  Neuroimage       Date:  2011-02-12       Impact factor: 6.556

Review 9.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

10.  Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis.

Authors:  Yael Barhum; Sharon Gai-Castro; Merav Bahat-Stromza; Ran Barzilay; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2009-11-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.